PRISMAP workshops

Deliverable D7.5 PRISMAP workshops This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 101008571 (PRISMAP). This document reflects only the view of the author(s). The Agency is not responsible for any use that may be made of the information it contains. 2 Project Acronym PRISMAP Project Title The European medical isotope programme: Production of high purity isotopes by mass separation Grant Agreement No. 101008571 Topic INFRAIA-02-2020: Integrating Activities for Starting Communities Project start date 01 May 2021 Nature Other Dissemination level Public Due date M54 Date of delivery M54 Lead partner KULeuven (replacing SCIPROM) Contributing partners SCIPROM, all Authors Thomas Elias Cocolios (KULeuven), Peter Ulrich (SCIPROM) Reviewer Kirsten Leufgen (SCIPROM) Point of Contact Thomas Elias Cocolios Institution KULeuven E-mail thomas.c[email protected] Phone +32473653950 © PRISMAP 2021. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. 3 Revision History Version Date Author Comment 0.1 09.10.2025 Thomas Elias Cocolios First draft 0.2 13.10.2025 Peter Ulrich, Thierry Stora, Ferid Haddad Additional input on the different events 0.3 20.10.2025 Thomas Elias Cocolios Consolidated version 0.9 21.10.2024 Kirsten Leufgen, Peter Ulrich Final input on the different events, review, version for final review of the general assembly 1.0 27.10.2025 Kirsten Leufgen Final version, approved by the general assembly 4 Contents Abbreviations 5 Participant short names 5 Summary 6 1. Engaging with the scientific community 7 2. PRISMAP workshops 8 2.1 Format of the PRISMAP workshops 8 2.2 List of the PRISMAP workshops at major conferences 8 2.2.1 EANM 2021 8 2.2.2 International Symposium on Trends in Radiopharmaceuticals 2023 8 2.2.3 Auger Symposium 9 2.2.4 Workshop on radionuclide production and medical applications 9 2.2.5 EANM 2025 9 3. Other scientific meetings 9 4. Conclusions and outlook 10 5 Abbreviations EANM European Association of Nuclear Medicine IAEA International Atomic Energy Agency Participant short names CERN European organization for nuclear research NPL National Physical Laboratory PSI Paul Scherrer Institut CEA Commissariat à l’énergie atomique et aux énergies alternatives IST-ID Associação do Instituto Superior Técnico para a IST-ID Investigação e Desenvolvimento DTU Danmarks Tekniske Universitet CHUV Centre hospitalier universitaire vaudois GANIL Grand Accélérateur National d’Ions Lourds SCK CEN Studiecentrum voor Kernenergie / Centre d'étude de l'énergie nucléaire ARRONAX Groupement d’intérêt public ARRONAX ESS European spallation source ERIC TUM Klinikum rechts der Isar der technischen Universität München KULeuven Katholieke Universiteit Leuven MedAustron Entwicklungsund Betriebsgesellschaft MedAustron GmbH SCIPROM SCIPROM Sàrl MUI Medizinische Universität Innsbruck ILL Institut Max von Laue - Paul Langevin JRC JRC -Joint Research CentreEuropean Commission NCBJ Narodowe Centrum Badań Jądrowych GSI GSI Helmholtzzentrum fr Schwerionenforschung GmbH LU Latvijas Universitāte INFN Istituto Nazionale di Fisica Nucleare UiO Universitetet i Oslo 6 Summary PRISMAP has thoroughly engaged with the scientific community to promote its services but also to report its findings and results from its users. Some of this engagement was done through the organisation of dedicated session at major international events, in order to reach an audience that might not already be aware of PRISMAP and its services. We have organised five such events throughout the duration of the PRISMAP project, including two at the international congress of EANM. Those events have been very successful, resulting in increased membership to the PRISMAP Community and shaping future collaborations, some of which have been concretised in the PRISMAP+ proposal. 7 1. Engaging with the scientific community Besides PRISMAP’s engagement to its users, our consortium has also strived to inform on its services and disseminate its findings and that of its user projects to the broad scientific community. This has been one of the pillars of the dissemination strategy within PRISMAP, which dissemination team regularly identified national and international events of relevance for our consortium and ensured proper representation at those events. Within the scientific community, we have regularly engaged with the PRISMAP Community 1 , which features those researchers who have direct interest in our findings. However, we have also further engaged with the scientific community at large through the organisation of dedicated workshops or sessions at large international events. Those events are presented below. Keynote lecture by Jean-Pierre Pouget at the Auger Symposium in Montpellier on 7 September 2023. 1 For more information on the PRISMAP Community, please refer to PRISMAP D7.4. 8 2. PRISMAP workshops 2.1 Format of the PRISMAP workshops Given the main target audience of PRISMAP is the nuclear medicine community, our dissemination strategy has targeted the annual congress of the European Association of Nuclear Medicine (EANM), as this is the flagship event of the community. When relevant, we have also joined other international events, where we could provide targeted added value while reaching out to an audience that we might otherwise not directly address. Those dedicated sessions always featured a generic introduction to PRISMAP and its role in the European infrastructure landscape, including the presentation of our portfolio and our production and biomedical research infrastructure. It was typically followed by thematic contributions from the consortium, from the PRISMAP Industrial Board, or from PRISMAP users, as relevant to the main event where the session was held. Most of those sessions were delivered as talks followed by discussion sessions, though we have also held networking events in the margin of such sessions, or organised a panel discussion, depending on the format best suited for the specific event. 2.2 List of the PRISMAP workshops at major conferences 2.2.1 EANM 2021  ‘PCS-8: Novel radionuclides for theranostics on the horizon’  Novel Radionuclides for Theranostics - What for? (Christophe Deroose, KULeuven)  PRISMAP – The European medical isotope programme providing novel medical radionuclides (Thierry Stora, CERN)  The technical challenges to provide novel radionuclides (Mattia Manzolaro, INFN)  Mass separation techniques – the way to high quality? (Renata Mikolajczak, NCBJ)  Novel Radionuclides - Preclinical Proof of Concept (Cristina Müller, PSI)  Novel Radionuclides - But in Right Quality and for the Right Target (Dana Niculae, IFIN-HH, Bucharest)  Novel Radionuclides - What Do We Already Know in Clinical Applications? (Isabel Rauscher, TUM)  Novel Radionuclides - Don’t Forget the Regulatory Side (Oliver Neels, HZDR, Dresden)  Online due to the COVID-19 pandemic  11 October 2021  https://www.youtube.com/watch?v=ZOU6w1ScL3w & https://web.archive.org/web/20211102060444/https:/eanm21.eanm.org/ for partial information  Number of participants not disclosed 2.2.2 International Symposium on Trends in Radiopharmaceuticals 2023  ‘Academia meets industry (PRISMAP experience)’  PRISMAP questionnaire to the community (Maija Radzina, LU)  Emerging therapeutic radioisotopes (Ulli Köster, ILL)  Sm-153 with high molar activity for targeted radionuclide therapy (Michiel van de Voorde, SCK CEN)  Challenges and opportunities in the production of RPs: industry perspective (Cristiana GameiroParis, IBA, Belgium)  Preclinical imaging of challenging isotopes including alpha emitters for oncological applications (George Loudos, Bioemtech, Greece)  IAEA Headquarters, Vienna International Center, Austria  18 April 2023, 16:00-17:30 (CET)  Plenary session followed by a networking event  https://www.iaea.org/events/istr-2023 9  70 participants 2.2.3 Auger Symposium  ‘PRISMAP Session’  Production of Auger emitters in PRISMAP (Mikael Jensen, DTU)  Evaluation of the therapeutic potential of [Cu-64]CuCl2 in 3D models of glioblastoma (Filipa Mendes, University of Lisbon)  Possibilities and options for production of Auger emitters in PRISMAP (Thierry Stora, CERN)  Montpellier, France  7 September 2023, 11:45—12:30 (CET)  In-person meeting  https://auger-symposium.com  50 participants 2.2.4 Workshop on radionuclide production and medical applications  ‘PRISMAP’  CERN – The European medical radionuclides programme (Thierry Stora, CERN)  The production at DTU and dispatch of research radionuclides in PRISMAP - an input to PRISMAP (Mikael Jensen, DTU)  Investigations and options for future involvement of ESS in the long term for medical isotopes (Luca Zanini, ESS)  Oslo, Norway  14 May 2025, 09:00—10:30  In-person meeting  https://www.nnrc.uio.no/english/news-and-events/events/radionuclide-production-and-medicalapplication.html  40 participants 2.2.5 EANM 2025  ‘PRISMAP’  The PRISMAP project – past & future (Thierry Stora, CERN)  A PRISMAP user’s experience (Eleni Gourni, Inselspital, Bern)  PRISMAP radionuclides – translation activities (Clemens Decristoforo, MUI)  Barcelona, Spain  5 October 2025, 14:00—14:30  EU Affair Track  https://eanm25.eanm.org  30 participants 3. Other scientific meetings Besides those events, PRISMAP has been strategically attending many scientific meetings that will be listed in the dissemination table of our final report. Moreover, PRISMAP has organised several scientific events to disseminate its findings, either as online webinars, public sessions to our consortium meetings, or dedicated workshops from our different work packages. The details of those events are reported in the PRISMAP deliverable D7.4.